Matches in Wikidata for { <http://www.wikidata.org/entity/Q97524510> ?p ?o ?g. }
- Q97524510 description "article scientifique publié en 2020" @default.
- Q97524510 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q97524510 description "scientific article published on 30 June 2020" @default.
- Q97524510 description "wetenschappelijk artikel" @default.
- Q97524510 description "наукова стаття, опублікована 30 червня 2020" @default.
- Q97524510 name "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 name "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 type Item @default.
- Q97524510 label "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 label "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 prefLabel "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 prefLabel "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 P1433 Q97524510-186E9F61-72A0-4DD3-8B7B-E4E7DEB82DFE @default.
- Q97524510 P1476 Q97524510-B4ED7AC2-B6DB-40D8-AFC5-8B379174CB09 @default.
- Q97524510 P2093 Q97524510-061C83C4-A220-4158-88B9-34EC8FE4C62E @default.
- Q97524510 P2093 Q97524510-09AD01D9-D000-49AE-9889-0EFB1E957ED7 @default.
- Q97524510 P2093 Q97524510-0C9F680C-5304-4CFE-8365-38AC729F93C2 @default.
- Q97524510 P2093 Q97524510-1164E22B-20FF-4040-BE5C-10D81BCE8DA8 @default.
- Q97524510 P2093 Q97524510-138E5331-12F5-43E7-86B5-B9D5A20E1C81 @default.
- Q97524510 P2093 Q97524510-1C69C3D8-4641-459A-9329-3D96D36A86C4 @default.
- Q97524510 P2093 Q97524510-22DFAC0B-5FBC-4E36-97E9-6AA771DABC7C @default.
- Q97524510 P2093 Q97524510-85CA2A9F-F5EB-498D-939A-288695DE63FA @default.
- Q97524510 P2093 Q97524510-9022645E-057C-4D9C-873F-A7101F765C3D @default.
- Q97524510 P2093 Q97524510-B1CBB640-0426-40FD-B8E8-79E4E8E7B57F @default.
- Q97524510 P2093 Q97524510-CD70E0EA-5F99-40CE-9A26-1B1288BFDFE3 @default.
- Q97524510 P2093 Q97524510-DADD37A3-DD7C-4669-AB23-856F02196D4C @default.
- Q97524510 P2093 Q97524510-F5EF0EAE-D248-492D-9B40-44ABC82DD328 @default.
- Q97524510 P2093 Q97524510-FDCA882E-9AE2-4903-8EF0-5D96EADC4A23 @default.
- Q97524510 P2860 Q97524510-09DAB49D-668A-4667-8040-336D0D844F36 @default.
- Q97524510 P2860 Q97524510-16A08749-FCEE-4390-85D8-55F2B3AA58D3 @default.
- Q97524510 P2860 Q97524510-1A8868DA-DB74-4BE6-9D15-8E51134AE6E9 @default.
- Q97524510 P2860 Q97524510-381F030F-7EB4-4E05-9A2C-A2A0BF937A4B @default.
- Q97524510 P2860 Q97524510-3A88A4DB-DA2D-401C-8FEE-72B63B342405 @default.
- Q97524510 P2860 Q97524510-3DE2C7C6-346D-4BB3-B770-CDA2BD7AA875 @default.
- Q97524510 P2860 Q97524510-405C4109-DB54-491E-A91D-2A7AE7A3E47D @default.
- Q97524510 P2860 Q97524510-41250379-269F-4670-B99C-845A014D61EA @default.
- Q97524510 P2860 Q97524510-53F3099A-6050-4E31-9B47-6BAB5524B033 @default.
- Q97524510 P2860 Q97524510-6285D4B6-51C5-42D4-8B42-E16E214195F5 @default.
- Q97524510 P2860 Q97524510-7D6FD808-B6B1-46A5-9F7B-6D4C7BF28DCE @default.
- Q97524510 P2860 Q97524510-85FE4944-23B1-4671-9DD5-682790D54895 @default.
- Q97524510 P2860 Q97524510-8816A42C-F7EC-4D0E-9481-A3D6754702E1 @default.
- Q97524510 P2860 Q97524510-95DE27FC-8017-4470-9EA9-8FF9BE9D67DB @default.
- Q97524510 P2860 Q97524510-9D3A4BD9-2936-48C0-A249-3A64EAC1C7DE @default.
- Q97524510 P2860 Q97524510-9DC2051D-38CF-48F4-8D4B-4EA04B7576FC @default.
- Q97524510 P2860 Q97524510-A3E3A30E-E770-4AA1-8E73-980227DC6F84 @default.
- Q97524510 P2860 Q97524510-A8A34638-B0EC-4895-A99F-691B631A0416 @default.
- Q97524510 P2860 Q97524510-A8F94927-1DC4-4456-8011-EC966C313C49 @default.
- Q97524510 P2860 Q97524510-B066471B-647C-4737-911D-73BC30230F36 @default.
- Q97524510 P2860 Q97524510-B5CD8B03-FAE8-4C6C-81DE-A60DAEF0A0C1 @default.
- Q97524510 P2860 Q97524510-B66E04AE-07EC-423D-8811-A24BDABB09E2 @default.
- Q97524510 P2860 Q97524510-BAA9AD86-7560-453D-A287-C085D1D08A5E @default.
- Q97524510 P2860 Q97524510-BDFFFB69-66FA-41FD-ACE1-5BD3B01053CE @default.
- Q97524510 P2860 Q97524510-C093ABE9-58F3-49EB-93AE-AFA607C78E78 @default.
- Q97524510 P2860 Q97524510-C7A39EBD-3D6B-4C51-BD87-A19221EA4978 @default.
- Q97524510 P2860 Q97524510-CE1677B7-024C-4D0E-85C5-7B8944B9EF4E @default.
- Q97524510 P2860 Q97524510-CEE1F1B5-3C02-4671-BA3B-E37EDB0B0602 @default.
- Q97524510 P2860 Q97524510-D1A4253E-74E6-428A-B81E-5B8E540C0DCE @default.
- Q97524510 P2860 Q97524510-D29E8C13-D9C6-403A-872C-A6C59CF0B850 @default.
- Q97524510 P2860 Q97524510-DA4579F4-3891-45F0-B6A6-80D84F32A11D @default.
- Q97524510 P2860 Q97524510-DE9AC4B2-52D0-4CE8-955A-54134BEF050F @default.
- Q97524510 P2860 Q97524510-E7056070-38C1-4479-A752-22A36F2324DF @default.
- Q97524510 P304 Q97524510-B05938A3-5C97-4FEB-8DC1-B69448B35523 @default.
- Q97524510 P31 Q97524510-4CF71838-03B8-42F5-82D4-2FB05E25609A @default.
- Q97524510 P356 Q97524510-4BCD4E6C-D006-428F-BE15-F848EB4CB2B0 @default.
- Q97524510 P433 Q97524510-9D492F7D-380C-4C04-B388-4D6AFFBE8B75 @default.
- Q97524510 P478 Q97524510-316B1D26-B8EF-4EB4-B5F0-2D01BD1ACDA8 @default.
- Q97524510 P577 Q97524510-421C61AA-6172-4E55-98B5-B19C9BC1E0A5 @default.
- Q97524510 P698 Q97524510-8FD844C4-C857-4898-994C-EC6C0BDCADB6 @default.
- Q97524510 P921 Q97524510-9210759A-2F3C-40D0-89A7-284738E08069 @default.
- Q97524510 P932 Q97524510-48F0830A-ABA9-4B6A-80B6-CF1497A420D8 @default.
- Q97524510 P356 ONCOTARGET.27652 @default.
- Q97524510 P698 32655840 @default.
- Q97524510 P1433 Q1573155 @default.
- Q97524510 P1476 "Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib" @default.
- Q97524510 P2093 "Alexandre Janel" @default.
- Q97524510 P2093 "Alexis Genthon" @default.
- Q97524510 P2093 "Carole Colin-Gil" @default.
- Q97524510 P2093 "Denis Guyotat" @default.
- Q97524510 P2093 "Franck Emmanuel Nicolini" @default.
- Q97524510 P2093 "Françoise Huguet" @default.
- Q97524510 P2093 "Jean-Michel Cayuela" @default.
- Q97524510 P2093 "Lydia Campos" @default.
- Q97524510 P2093 "Marc Berger" @default.
- Q97524510 P2093 "Nadine Cadoux" @default.
- Q97524510 P2093 "Pascale Cohny-Makhoul" @default.
- Q97524510 P2093 "Pascale Flandrin-Gresta" @default.
- Q97524510 P2093 "Sandrine Hayette" @default.
- Q97524510 P2093 "Sandrine Saugues" @default.
- Q97524510 P2860 Q24683696 @default.
- Q97524510 P2860 Q28204172 @default.
- Q97524510 P2860 Q28292463 @default.
- Q97524510 P2860 Q29614339 @default.
- Q97524510 P2860 Q30009436 @default.
- Q97524510 P2860 Q33430207 @default.
- Q97524510 P2860 Q33603077 @default.
- Q97524510 P2860 Q34079452 @default.
- Q97524510 P2860 Q34557009 @default.
- Q97524510 P2860 Q34657509 @default.
- Q97524510 P2860 Q34747837 @default.
- Q97524510 P2860 Q35561038 @default.